Apeximmune’s mission is to harness the power of the immune system to treat cancer and autoimmune disease. We focus on discovering and pioneering powerful therapeutic antibodies against innovative targets that shift the balance of immune cell activity and deliver lasting, transformative medicines.
Apeximmune is dedicated to developing monoclonal antibody immunotherapies to benefit cancer patients resistant to current standard-of-care treatments. We seek to discover the most effective immunotherapies that enhance tumoricidal effector cell function and create an immune microenvironment conducive to sustainable tumor eradication.